Now a new survey shows that, natural products continue to remain top of mind for many women when it comes to the personal care beauty products.
The second annual Green Beauty Barometer survey questioned more than 1,000 U.S. women aged 18 and up about their beauty consumer habits and desires including: skin care; hair care; makeup; sunscreen; fragrance and nail care. Among the notable findings are:
- The Survey has found that more than half 55% of all women check ingredient labels on beauty products prior to purchase
- over 35 % intend to purchase more all-natural beauty products in the next 2 years than they currently do
- 73 %of millennial women believe it is important to buy all-natural cosmetics.
- Women with children in the home (69 percent) are more likely to value natural beauty products compared to women without children in the home (56 percent).
According to a recent survey by the EWG, the majority of Americans believe that at least some of the chemicals used in personal care products have been cleared for safety by the government when, in fact, there is barely any regulation of the industry. Another survey, this one conducted by both the Federal Trade Commission and the U.S. Department of Agriculture, found that many consumers mistakenly believe personal care products with organic claims meet government standards and that they contain only organic ingredients.
Green Beauty Barometer survey, Gran says “They think ‘good for you’ and ‘from the earth.’” The next step is to get those in the industry to agree. For more information on Indian cosmetic registration refer our blog “Cosmetic Registration in India – An Overview”
Other News
High-Value Medical Equipment: Customs Exemptions
High-Value Medical Equipment The Central Drugs Standard Control Organization (CDSCO) and the Central Board of Indirect Taxes & Customs have released a new circular, “F.No.401/40/2021-Cus.III,” detailing updated policies on the import of used high-end medical […]
Read MoreSEC – Special Expert Committee
The Central Drugs Standard Control Organization (CDSCO) has recently published an article titled “SEC – Special Expert Committee, Medical Devices”. Key highlights include the streamlined processes for CDSCO application evaluations, preparation and significance of briefing […]
Read More
ErlySign Oral Cancer Detection Technology Gets CDSCO Nod
ErlySign, a Nagpur-based biotech startup, has received approval from the Central Drugs Standard Control Organization (CDSCO) to conduct large-scale clinical trials for its novel oral cancer detection technology. The approval for ErlySign follows a rigorous […]
Read MoreAdditional Steps Announced by FDA to Modernize Clinical Trials
The U.S. Food and Drug Administration has made draft guidance available with updated recommendations for good clinical practices (GCPs), which are intended to modernize the clinical trial design and conduct while maintaining data integrity and […]
Read MoreAccreditation and Registration Numbers for Foreign Manufacturers Publication by PMDA
This article deals In accordance with the Pharmaceuticals and Medical Devices Act (PMD Act) of Japan, foreign businesses that wish to produce pharmaceuticals, quackery products, active pharmaceutical ingredients (APIs), or medical devices abroad and import […]
Read MoreBSI New Certification to Mitigate Antimicrobial Resistance Risk in Antibiotic Manufacturing
BSI, the business improvement and standards company, has developed a new certification to mitigate the risk of antimicrobial resistance (AMR) in antibiotic manufacturing. The certification, called the Minimized Risk of Antimicrobial Resistance (AMR) certification, will […]
Read More
TUV SUD Inspects IVD Medical Devices’ Cyber Security
The growing digital connectivity of medical infrastructure is resulting in complicated systems with a plethora of diverse interfaces that are potentially vulnerable to assault. The IVD requires producers to provide proof of cyber security before […]
Read More
TGA Supports MHRA’s New Regulations
The TGA made a commitment to support the MHRA‘s new Regulations worldwide recognition framework for pharmaceuticals. Following the UK’s exit from the European Union, a new international recognition framework for medicines has been developed specifically […]
Read More
